ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for people who are considering taking part in clinical trials and would like to find out more about what’s involved, why clinical trials are important and what the benefits of taking part in trials are. You can also find out about current clinical trials going on in ICTU and how to get involved.

Clinical Trials Search


CurrentAll Trials


Trial Details

  • Trial statusCompleted
  • Study email contactLEOPARDS@imperial.ac.uk
  • Chief InvestigatorProf Anthony Gordon
  • Project managerDr Farah Al-Beidh
  • SponsorImperial College London
  • ISRCTN numberISRCTN12776039
  • PhaseIIb

Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis

Design and Objective

The main objectives of this trial are: 1. To ascertain if levosimendan reduces the incidence and severity of organ dysfunction as compared to placebo in adult patients who have septic shock. 2. To identify the effect of levosimendan on individual organ function in septic shock. 3. To establish the safety profile and pharmacokinetics of levosimendan in this group of patients.

Key inclusion criteria

- Hypotension, despite adequate intravenous fluid resuscitation, requiring vasopressor infusion AND two of the following: - Fever (>38C) or hypothermia (<36C) - Tachycardia (heart rate >90 bpm) - Tachypnoea (respiratory rate >20 breaths per min or PaCO2 <4.3 kPa) or on mechanical ventilation - Abnormal leukocyte count (>12,000/<4000 cells/mm3)

Study Disclaimer Statement